Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

NCT02118896 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

850

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Transplantation
Liver Transplantation
Kidney Transplantation

Interventions

DRUG: FK506E

Sponsor

Astellas Pharma Europe Ltd.